Foster Wheeler buys pharma construction consultancy Biokinetics

Foster Wheeler has strengthened its position in the biotech and pharma markets by completing the acquisition of 100% of stock in Biokinetics Inc from MPA Holdings LP.

Foster Wheeler Expands Biopharma Capabilities with Acquisition of Biokinetics Inc.

Strategic Business Sale Strengthens Market Presence

Engineering and construction giant Foster Wheeler has announced the acquisition of 100% of Biokinetics Inc. from MPA Holdings LP. This strategic business sale marks a significant step in Foster Wheeler’s expansion into the life sciences industry, particularly within the pharmaceuticals, biotechnology, and healthcare sectors.

Biokinetics, a Philadelphia-based process systems design firm, specializes in providing advanced solutions for the biopharmaceutical industry. With expertise in bioprocess unit operations, including fermentation, mammalian cell culture, vaccine processing, and high-purity water systems, Biokinetics has earned a strong reputation as an industry leader.

Under the terms of the purchase agreement, the existing principals—William Brydges, James Dougherty, and Anthony Contino—will continue to lead Biokinetics, ensuring continuity and leveraging their expertise to drive future growth. While the financial details of the acquisition remain undisclosed, the transaction is expected to bolster Foster Wheeler’s market share and capabilities within the biopharmaceutical sector.

Strengthening Biopharmaceutical Expertise

Foster Wheeler’s Chief Operating Officer, Umberto Della Salla, emphasized the strategic significance of the acquisition.

“The pharmaceuticals, biotechnology, and healthcare market is a core segment for Foster Wheeler, and we are committed to growing our presence in this space,” Della Salla stated. “This acquisition aligns with our strategy to complement organic growth with targeted acquisitions. By integrating Biokinetics’ specialized expertise, we can offer more comprehensive solutions to our global clients.”

Della Salla also highlighted the strong working relationship Foster Wheeler has already established with Biokinetics. He expressed confidence that the combined expertise of both companies will bring substantial value to pharmaceutical companies developing projects in the U.S. and internationally.

Exit Planning and Advisory

The business sale was facilitated by Mark Sapsford, who advised Biokinetics’ shareholders throughout the acquisition process. This strategic exit planning ensures a seamless transition while maintaining the operational and leadership continuity necessary for ongoing success.

About Foster Wheeler

Foster Wheeler Ltd. is a globally recognized engineering and construction firm with a diversified portfolio spanning upstream oil and gas, LNG, refining, petrochemicals, power, and life sciences. Headquartered in Hamilton, Bermuda, with operational headquarters in Clinton, New Jersey, Foster Wheeler is known for delivering cutting-edge engineering, procurement, and construction solutions worldwide.

About Biokinetics

Founded in 1996, Biokinetics has established itself as a leader in process systems design for the biopharmaceutical industry. The company’s expertise covers critical areas such as bacterial and yeast fermentation, virus processing for vaccines, plasma-derived product development, pharmaceutical fill-finish, and process optimization. With operations in Pennsylvania, California, North Carolina, and Ireland, Biokinetics employs approximately 130 professionals dedicated to advancing biopharmaceutical engineering.

This acquisition represents a major step forward in Foster Wheeler’s long-term growth strategy. By integrating Biokinetics’ capabilities, Foster Wheeler aims to further solidify its position as a leading provider of engineering solutions for the evolving pharmaceutical and biotechnology landscape.

More building consultancy related M&A deal news: Fire engineering consultancy JGA acquired by Jensen Hughes

Client feedback

"Thank you for helping me and my partners when we sold our business.

"I believe due to your personal efforts, we received 25 to 50% more for our business than we would have otherwise.

"The process you laid out and the effort you expended, along with your professional attitude and personality kept the discussions going with multiple suitors, even with some very difficult and tough negotiators.

"And, your support in vetting the potential acquirers so that we not only maximised the price, we did so with a partner that, also, met all of our non-monetary requirements."

Bill Bridges, Owner

Biokinetics Inc

We'd love to hear your story

Let's chat about your future plans. We can help you get clear on where your business journey is going.

meet mark sapsford for an informal chat